Abstract
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting, the Collaborative Research Network (CRN) met to present updates on several projects. These included the GRAPPA-Industry biomarker projects, Axial Psoriatic Arthritis Molecular and Clinical Characterisation Study, Axial Involvement in Psoriatic Arthritis Cohort (AXIS) study, and the Health Initiatives in Psoriasis and Psoriatic Arthritis Consortium European States (HIPPOCRATES). The meeting concluded with a discussion on pathways to further academia-industry collaboration.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference11 articles.
1. Basic science session 1. Biomarkers for psoriatic arthritis treatment response and joint damage progression: an update on 2 Industry-GRAPPA projects;Waddington;J Rheumatol,2022
2. POS1045 MASS SPECTROMETRY-BASED PROTEOMICS FOR THE IDENTIFICATION OF CANDIDATE SERUM PROTEIN BIOMARKERS THAT MAY PREDICT TREATMENT RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS
3. Coleman O , Wundervald B , Zhou R , Identification of serum protein biomarkers at baseline to distinguish radiographic progressors from non-progressors in patients with active psoriatic arthritis [abstract]. Arthritis Rheumatol 2021;73 Suppl 9.
4. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of spondyloarthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA);Poddubnyy;Ther Adv Musculoskelet Dis,2021
5. HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis;FitzGerald;Nat Rev Rheumatol,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献